Results 181 to 190 of about 9,833 (206)

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

Lancet, The, 2013
W David Strain, Päivi Maria Paldánius DMed   +1 more
exaly  

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

JACC: Heart Failure, 2018
John J V Mcmurray, Piotr Ponikowski
exaly  

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Diabetologia, 2006
Niina Hanna Talvikki Matikainen, Marja-Riitta Taskinen   +1 more
exaly  

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

Neurotherapeutics, 2019
Noha H Sayed, Nevine Fathy, Mona A Kortam   +2 more
exaly  

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice

Diabetologia, 2018
Marta Olivares, Audrey M Neyrinck, Martin Beaumont   +2 more
exaly  

Vildagliptin

Drugs of the Future, 2004
null McIntyre, J.A., null Castaner, J.
openaire   +1 more source

Effect of Vildagliptin on Hepatic Steatosis

Journal of Clinical Endocrinology and Metabolism, 2015
Mavin Macauley, Ahmad Al-Mrabeh, Roy Taylor   +2 more
exaly  

The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients

Journal of Clinical Endocrinology and Metabolism, 2007
Yan-Ling He, Ralph A Defronzo
exaly  

Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant rats

British Journal of Pharmacology, 2013
Nipon Chattipakorn
exaly  

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

Diabetologia, 2007
exaly